This is a preview of subscription content, log in via an institution to check access.
Reference
Clinical and Economic Impact of Substituting Dexmedetomidine for Propofol due to a US Drug Shortage: Examination of Coronary Artery Bypass Graft Patients at an Urban Medical Centre. PharmacoEconomics : 20 Nov 2013. Available from: URL: http://dx.doi.org/10.1007/s40273-013-0116-8
Additional information
* during the time of propofol shortage
Rights and permissions
About this article
Cite this article
Dexmedetomidine improves outcomes, saves costs in CABG. PharmacoEcon Outcomes News 693, 5 (2013). https://doi.org/10.1007/s40274-013-0928-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0928-y